TB
Elite in Metastatic Brain Tumor
Check Dr. Tracy T. Batchelor's experience treating your condition:
About Dr. Tracy T. Batchelor

Tracy Batchelor is a Neurologist in Boston, Massachusetts. Batchelor has been practicing medicine for over 33 years and is rated as an Elite expert by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 19 other conditions, according to our data. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Tissue Biopsy, and Gamma Knife Radiosurgery. He is licensed to treat patients in Massachusetts. Batchelor is currently accepting new patients.

His clinical research consists of co-authoring 254 peer reviewed articles and participating in 16 clinical trials in the past 15 years. In particular, he has co-authored 17 articles in the study of Metastatic Brain Tumor.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Tracy T. Batchelor it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
60 Fenwood Rd, 1st Floor, Boston, MA 02115
Other Locations
450 Brookline Ave, Boston, MA 02215
Background & Education
Graduate Institution
Emory University School Of Medicine, 1990
Specialties
Neurology
Licenses
Psychiatry & Neurology in MA
Hospital Affiliations
Milford Regional Medical Center
Brigham And Womens Hospital
Massachusetts General Hospital
Dana Farber Cancer Institute
Beth Israel Deaconess Hospital - Plymouth
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


15 Clinical Trials

Prospective Randomized Placebo-Controlled Trial of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)
A Randomized Phase II Trial of Myeloablative Versus Non-Myeloablative Consolidation Chemotherapy for Newly Diagnosed Primary CNS B-cell Lymphoma
A Study to Evaluate Vascular Normalization in Patients With Recurrent Glioblastoma Treated With Bevacizumab Using FMISO PET and Vascular MRI
A Study to Evaluate Vascular Normalization in Patients With Recurrent Glioblastoma Treated With Bevacizumab Using [11C]Temozolomide PET and Vascular MRI
An Open-Label, Phase 2 Trial of Orally Administered PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma (GBM)
A Phase Ib/II Study of AZD2171 in Combination With Daily Temozolomide and Radiation in Patients With Newly Diagnosed Glioblastoma Not Taking Enzyme-Inducing Anti-epileptic Drugs
A Feasibility Assessment and a Phase I/II Trial of MLN518 for Treatment of Patients With Recurrent Glioblastoma
An Open Label, Phase 2 Trial of Orally Administered Bosutinib (SKI-606) in Adult Patients With Recurrent Glioblastoma (GBM)
A Phase I Study of Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
A Phase I Study of PRK787/ZK 222584 in Combination With Daily Temozolomide and Radiation in Patients With Newly Diagnosed Glioblastoma
A Phase II Study of AZD2171 in Recurrent Glioblastoma
Phase I/II Trial of Oxaliplatin as Neoadjuvant Treatment in Adults With Newly Diagnosed Glioblastoma Multiforme
View 14 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Elite
Elite
Elite